Stocks
Viveve Medical Financial Statements (VIVE) |
||||||||||
| Viveve Medicalsmart-lab.ru | % | 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 16.03.2018 | 15.03.2019 | 19.03.2020 | 18.03.2021 | 17.03.2022 | 10.11.2022 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 15.3 | 18.5 | 6.57 | 5.48 | 6.43 | 6.83 | |||
| Operating Income, bln rub | -33.7 | -45.0 | -29.9 | -18.5 | -21.6 | -21.1 | ||||
| EBITDA, bln rub | ? | -33.7 | -45.0 | -28.9 | -18.8 | -20.6 | -20.4 | |||
| Net profit, bln rub | ? | -36.6 | -49.2 | -46.7 | -21.2 | -22.8 | -23.9 | |||
| OCF, bln rub | ? | -34.9 | -43.1 | -31.2 | -15.2 | -12.9 | -16.2 | |||
| CAPEX, bln rub | ? | 0.905 | 2.14 | 1.09 | 0.781 | 0.456 | 0.595 | |||
| FCF, bln rub | ? | -35.8 | -45.2 | -32.3 | -16.0 | -13.3 | -16.8 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 4.69 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -19.6% | ||||
| OPEX, bln rub | 41.2 | 52.3 | 31.0 | 18.8 | 22.2 | 22.3 | ||||
| Cost of production, bln rub | 7.84 | 11.2 | 5.55 | 5.18 | 5.81 | 5.71 | ||||
| R&D, bln rub | 12.3 | 13.7 | 8.59 | 5.13 | 9.67 | 8.72 | ||||
| Interest expenses, bln rub | 3.17 | 4.37 | 4.35 | 0.910 | 1.000 | 1.11 | ||||
| Assets, bln rub | 36.1 | 46.8 | 27.0 | 16.6 | 25.9 | 12.2 | ||||
| Net Assets, bln rub | ? | -2.60 | 4.91 | 16.5 | 6.97 | 15.1 | 1.18 | |||
| Debt, bln rub | 28.9 | 30.5 | 4.25 | 5.86 | 5.35 | 5.88 | ||||
| Cash, bln rub | 20.7 | 29.5 | 13.3 | 6.52 | 19.2 | 5.91 | ||||
| Net debt, bln rub | 8.22 | 1.01 | -9.06 | -0.66 | -13.8 | -0.03 | ||||
| Ordinary share price, rub | 4 970 | 1 050 | 12.6 | 4.70 | 1.14 | 0.907 | ||||
| Number of ordinary shares, mln | 0.017 | 0.031 | 0.125 | 1.57 | 10.1 | 10.7 | ||||
| Market cap, bln rub | 87 | 33 | 2 | 7 | 12 | 10 | ||||
| EV, bln rub | ? | 95 | 34 | -7 | 7 | -2 | 10 | |||
| Book value, bln rub | -3 | 5 | 17 | 7 | 15 | 1 | ||||
| EPS, rub | ? | -2 094 | -1 584 | -374.4 | -13.5 | -2.26 | -2.24 | |||
| FCF/share, rub | -2 044 | -1 456 | -259.0 | -10.2 | -1.32 | -1.58 | ||||
| BV/share, rub | -148.6 | 158.2 | 132.4 | 4.43 | 1.49 | 0.11 | ||||
| EBITDA margin, % | ? | -220.2% | -242.8% | -440.3% | -342.8% | -320.8% | -299.2% | |||
| Net margin, % | ? | -239.6% | -265.6% | -711.4% | -387.6% | -355.2% | -350.4% | |||
| FCF yield, % | ? | -41.1% | -138.7% | -2 056% | -216.5% | -115.9% | -174.0% | |||
| ROE, % | ? | 1 409% | -1 001% | -282.8% | -304.5% | -151.5% | -2 020% | |||
| ROA, % | ? | -101.5% | -105.0% | -173.2% | -127.7% | -88.1% | -196.8% | |||
| P/E | ? | -2.37 | -0.66 | -0.03 | -0.35 | -0.50 | -0.40 | |||
| P/FCF | -2.43 | -0.72 | -0.05 | -0.46 | -0.86 | -0.57 | ||||
| P/S | ? | 5.69 | 1.76 | 0.24 | 1.35 | 1.79 | 1.42 | |||
| P/BV | ? | -33.4 | 6.64 | 0.10 | 1.06 | 0.76 | 8.17 | |||
| EV/EBITDA | ? | -2.83 | -0.75 | 0.26 | -0.36 | 0.11 | -0.47 | |||
| Debt/EBITDA | -0.24 | -0.02 | 0.31 | 0.04 | 0.67 | 0.00 | ||||
| R&D/CAPEX, % | 1 364% | 640.3% | 790.2% | 656.2% | 2 120% | 1 466% | ||||
| CAPEX/Revenue, % | 5.92% | 11.6% | 16.6% | 14.3% | 7.10% | 8.72% | ||||
| Viveve Medical shareholders | ||||||||||
